Technical Analysis for GH - Guardant Health, Inc.

Grade Last Price % Change Price Change
grade D 73.98 0.54% 0.40
GH closed up 0.54 percent on Friday, December 6, 2019, on 47 percent of normal volume.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical GH trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -1.31%
20 DMA Resistance Bearish -1.62%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.62%
200 DMA Resistance Bearish 0.19%
Fell Below 20 DMA Bearish 0.19%
MACD Bearish Signal Line Cross Bearish 0.19%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.19%
Outside Day Range Expansion 0.19%
Fell Below 200 DMA Bearish -4.75%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.75%

Older signals for GH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Its Guardant Health Oncology Platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. In pursuit of its goal to manage cancer across all stages of the disease, Guardant Health has launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2, respectively. Since its launch in 2014, Guardant360 has been used by more than 5,000 oncologists, over 40 biopharmaceutical companies and all 27 of the National Comprehensive Cancer Network centers.
Medicine Biopharmaceutical Cancer Medical Specialties Disease Oncology Precision Medicine

Is GH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 112.21
52 Week Low 32.33
Average Volume 1,093,431
200-Day Moving Average 78.44
50-Day Moving Average 69.86
20-Day Moving Average 76.51
10-Day Moving Average 76.43
Average True Range 3.25
ADX 17.45
+DI 16.18
-DI 19.83
Chandelier Exit (Long, 3 ATRs ) 71.19
Chandelier Exit (Short, 3 ATRs ) 72.27
Upper Bollinger Band 81.61
Lower Bollinger Band 71.41
Percent B (%b) 0.25
BandWidth 13.32
MACD Line 0.97
MACD Signal Line 1.72
MACD Histogram -0.7574
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 77.57
Resistance 3 (R3) 77.91 77.05 76.97
Resistance 2 (R2) 77.05 76.14 76.88 76.77
Resistance 1 (R1) 75.52 75.58 75.09 75.18 76.57
Pivot Point 74.66 74.66 74.45 74.49 74.66
Support 1 (S1) 73.13 73.75 72.70 72.79 71.39
Support 2 (S2) 72.27 73.19 72.10 71.19
Support 3 (S3) 70.74 72.27 70.99
Support 4 (S4) 70.40